BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32501544)

  • 1. Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response.
    Carr DF; Turner RM; Pirmohamed M
    Br J Clin Pharmacol; 2021 Feb; 87(2):237-255. PubMed ID: 32501544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward.
    Lauschke VM; Zhou Y; Ingelman-Sundberg M
    Annu Rev Pharmacol Toxicol; 2024 Jan; 64():33-51. PubMed ID: 37506333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of pharmacogenetics in oncology.
    Miteva-Marcheva NN; Ivanov HY; Dimitrov DK; Stoyanova VK
    Biomark Res; 2020; 8():32. PubMed ID: 32821392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pharmacogenomics: the development of a science.
    Kalow W
    Hum Genomics; 2004 Aug; 1(5):375-80. PubMed ID: 15588498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives.
    Patel JN
    Pharmgenomics Pers Med; 2016; 9():65-77. PubMed ID: 27471406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Pharmacogenomics in Clinical Practice.
    Principi N; Petropulacos K; Esposito S
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?
    Simões AR; Fernández-Rozadilla C; Maroñas O; Carracedo Á
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33228198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: The impact of the human genome on interindividual variability in drug response.
    Kassogue Y; Fricke-Galindo I
    Front Genet; 2024; 15():1401604. PubMed ID: 38711917
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of TDM-based dose adjustments for taxane anticancer drugs.
    Muth M; Ojara FW; Kloft C; Joerger M
    Br J Clin Pharmacol; 2021 Feb; 87(2):306-316. PubMed ID: 33247980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics for Primary Care: An Overview.
    Rollinson V; Turner R; Pirmohamed M
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review of economic evaluations of therapeutic drug monitoring interventions for cancer treatments.
    Vithanachchi DT; Maujean A; Downes MJ; Scuffham P
    Br J Clin Pharmacol; 2021 Feb; 87(2):271-283. PubMed ID: 32692416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations When Applying Pharmacogenomics to Your Practice.
    Nicholson WT; Formea CM; Matey ET; Wright JA; Giri J; Moyer AM
    Mayo Clin Proc; 2021 Jan; 96(1):218-230. PubMed ID: 33308868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interface of Therapeutics and Genomics in Cardiovascular Medicine.
    Magavern EF; Kaski JC; Turner RM; Janmohamed A; Borry P; Pirmohamed M
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):663-676. PubMed ID: 33528719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of the Important Role of
    Taylor C; Crosby I; Yip V; Maguire P; Pirmohamed M; Turner RM
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33143137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Molecular targets for anticancer drug discovery and development.
    Ntwasa M; Dlamini Z
    Front Genet; 2024; 15():1374867. PubMed ID: 38633405
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacogenetics of Anticancer Drugs: Clinical Response and Toxicity.
    Siddique A; Bashir S; Abbas M
    Cancer Treat Res; 2023; 185():141-175. PubMed ID: 37306909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular cancer survivorship: Long-term toxicity and management.
    Shrem NS; Wood L; Hamilton RJ; Kuhathaas K; Czaykowski P; Roberts M; Matthew A; Izard JP; Chung P; Nappi L; Jones J; Soulières D; Aprikian A; Power N; Canil C
    Can Urol Assoc J; 2022 Aug; 16(8):257-272. PubMed ID: 35905486
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors Determining Plasticity of Responses to Drugs.
    Parnham MJ; Kricker JA
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk Factors for Venous Thromboembolism in Female Patients Undergoing Breast Surgery.
    Londero AP; Bertozzi S; Cedolini C; Neri S; Bulfoni M; Orsaria M; Mariuzzi L; Uzzau A; Risaliti A; Barillari G
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205736
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.